Erin K. Brenner Pear Therapeutics, Inc. (PEAR) insider trading activity
Erin K. Brenner is Chief Product Dev. Officer of Pear Therapeutics, Inc.. Currently has a direct ownership of 43,310 shares of PEAR, which is worth approximately $433. The most recent transaction as insider was on Jan 20, 2023, when has been sold 8,690 shares (Class A Common Stock) at a price of $1.13 per share, resulting in proceeds of $9,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
43.3K
0%
3M change
0%
12M change
Total Value Held
$433
Erin K. Brenner Transaction History
EKB
Erin K. Brenner
Chief Product Dev. Officer
Boston, MA